메뉴 건너뛰기




Volumn 14, Issue 10, 2014, Pages

Apolipoprotein C3 gene polymorphisms are not a risk factor for developing non-alcoholic fatty liver disease: A meta-analysis

Author keywords

Apolipoprotein; NAFLD; Polymorphisms

Indexed keywords

APOLIPOPROTEIN C3;

EID: 84908252666     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.23100     Document Type: Review
Times cited : (20)

References (26)
  • 1
    • 84860246738 scopus 로고    scopus 로고
    • APOC3 and PNPLA3 in non-alcoholic fatty liver disease: Need to clear the air
    • Duseja A, Aggarwal R. APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air. J Gastroenterol Hepatol. 2012;27(5):848-51.
    • (2012) J Gastroenterol Hepatol. , vol.27 , Issue.5 , pp. 848-851
    • Duseja, A.1    Aggarwal, R.2
  • 3
    • 0242492522 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis--a long-term follow-up study: Comparison with alcoholic hepatitis in ambulatory and hospitalized patients
    • Cortez-Pinto H, Baptista A, Camilo ME, De Moura MC. Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 2003;48(10):1909-13.
    • (2003) Dig Dis Sci. , vol.48 , Issue.10 , pp. 1909-1913
    • Cortez-Pinto, H.1    Baptista, A.2    Camilo, M.E.3    De Moura, M.C.4
  • 5
    • 10644220306 scopus 로고    scopus 로고
    • Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    • Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95.
    • (2004) Hepatology. , vol.40 , Issue.6 , pp. 1387-1395
    • Browning, J.D.1    Szczepaniak, L.S.2    Dobbins, R.3    Nuremberg, P.4    Horton, J.D.5    Cohen, J.C.6
  • 6
    • 78650774076 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground
    • Chitturi S, Wong VW, Farrell G. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol. 2011;26 Suppl 1:163-72.
    • (2011) J Gastroenterol Hepatol. , vol.26 , pp. 163-172
    • Chitturi, S.1    Wong, V.W.2    Farrell, G.3
  • 7
    • 78649622081 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver in a developing country is responsible for significant liver disease
    • Duseja A, Sharma B, Kumar A, Kapil S, Das A, Dhiman RK, et al. Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. Hepatology. 2010;52(6):2248-9.
    • (2010) Hepatology. , vol.52 , Issue.6 , pp. 2248-2249
    • Duseja, A.1    Sharma, B.2    Kumar, A.3    Kapil, S.4    Das, A.5    Dhiman, R.K.6
  • 9
    • 34047135689 scopus 로고    scopus 로고
    • APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome
    • Miller M, Rhyne J, Chen H, Beach V, Ericson R, Luthra K, et al. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome. Arch Med Res. 2007;38(4):444-51.
    • (2007) Arch Med Res. , vol.38 , Issue.4 , pp. 444-451
    • Miller, M.1    Rhyne, J.2    Chen, H.3    Beach, V.4    Ericson, R.5    Luthra, K.6
  • 10
    • 12144259379 scopus 로고    scopus 로고
    • Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population
    • Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288(2):E462-8.
    • (2005) Am J Physiol Endocrinol Metab. , vol.288 , Issue.2 , pp. E462-E468
    • Szczepaniak, L.S.1    Nurenberg, P.2    Leonard, D.3    Browning, J.D.4    Reingold, J.S.5    Grundy, S.6
  • 11
    • 0041349299 scopus 로고    scopus 로고
    • Research methods: Managing primary study quality in meta-analyses
    • Conn VS, Rantz MJ. Research methods: managing primary study quality in meta-analyses. Res Nurs Health. 2003;26(4):322-33.
    • (2003) Res Nurs Health. , vol.26 , Issue.4 , pp. 322-333
    • Conn, V.S.1    Rantz, M.J.2
  • 12
    • 0037024299 scopus 로고    scopus 로고
    • Quality of reporting of randomized trials as a measure of methodologic quality
    • Huwiler-Muntener K, Juni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. 2002;287(21):2801-4.
    • (2002) JAMA. , vol.287 , Issue.21 , pp. 2801-2804
    • Huwiler-Muntener, K.1    Juni, P.2    Junker, C.3    Egger, M.4
  • 13
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple, graphical test
    • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629- 34.
    • (1997) BMJ. , vol.315 , Issue.7109 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 14
    • 81255198296 scopus 로고    scopus 로고
    • The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver
    • Valenti L, Nobili V, Al-Serri A, Rametta R, Leathart JB, Zappa MA, et al. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J Hepatol. 2011;55(6):1409-14.
    • (2011) J Hepatol. , vol.55 , Issue.6 , pp. 1409-1414
    • Valenti, L.1    Nobili, V.2    Al-Serri, A.3    Rametta, R.4    Leathart, J.B.5    Zappa, M.A.6
  • 15
    • 79958160803 scopus 로고    scopus 로고
    • Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans
    • Sentinelli F, Romeo S, Maglio C, Incani M, Burza MA, Scano F, et al. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. Lipids Health Dis. 2011;10:93.
    • (2011) Lipids Health Dis. , vol.10 , pp. 93
    • Sentinelli, F.1    Romeo, S.2    Maglio, C.3    Incani, M.4    Burza, M.A.5    Scano, F.6
  • 17
    • 84862193848 scopus 로고    scopus 로고
    • Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
    • Peter A, Kantartzis K, Machicao F, Machann J, Wagner S, Templin S, et al. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content. Int J Obes (Lond). 2012;36(6):774-82.
    • (2012) Int J Obes (Lond). , vol.36 , Issue.6 , pp. 774-782
    • Peter, A.1    Kantartzis, K.2    McHicao, F.3    McHann, J.4    Wagner, S.5    Templin, S.6
  • 18
    • 84885381567 scopus 로고    scopus 로고
    • A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population
    • Verrijken A, Beckers S, Francque S, Hilden H, Caron S, Zegers D, et al. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Obesity (Silver Spring). 2013;21(10):2138-45.
    • (2013) Obesity (Silver Spring). , vol.21 , Issue.10 , pp. 2138-2145
    • Verrijken, A.1    Beckers, S.2    Francque, S.3    Hilden, H.4    Caron, S.5    Zegers, D.6
  • 19
    • 84897490706 scopus 로고    scopus 로고
    • Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population
    • Niu TH, Jiang M, Xin YN, Jiang XJ, Lin ZH, Xuan SY. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population. World J Gastroenterol. 2014;20(13):3655-62.
    • (2014) World J Gastroenterol. , vol.20 , Issue.13 , pp. 3655-3662
    • Niu, T.H.1    Jiang, M.2    Xin, Y.N.3    Jiang, X.J.4    Lin, Z.H.5    Xuan, S.Y.6
  • 20
    • 0026443622 scopus 로고
    • Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles
    • Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, et al. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest. 1992;90(5):1889-900.
    • (1992) J Clin Invest. , vol.90 , Issue.5 , pp. 1889-1900
    • Aalto-Setala, K.1    Fisher, E.A.2    Chen, X.3    Chajek-Shaul, T.4    Hayek, T.5    Zechner, R.6
  • 21
    • 0028069690 scopus 로고
    • Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E
    • de Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, et al. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem. 1994;269(3):2324-35.
    • (1994) J Biol Chem. , vol.269 , Issue.3 , pp. 2324-2335
    • de Silva, H.V.1    Lauer, S.J.2    Wang, J.3    Simonet, W.S.4    Weisgraber, K.H.5    Mahley, R.W.6
  • 22
    • 34248172313 scopus 로고    scopus 로고
    • Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions
    • Zheng C, Khoo C, Ikewaki K, Sacks FM. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions. J Lipid Res. 2007;48(5):1190-203.
    • (2007) J Lipid Res. , vol.48 , Issue.5 , pp. 1190-1203
    • Zheng, C.1    Khoo, C.2    Ikewaki, K.3    Sacks, F.M.4
  • 23
    • 0028881810 scopus 로고
    • Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
    • Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest. 1995;96(6):2601-5.
    • (1995) J Clin Invest. , vol.96 , Issue.6 , pp. 2601-2605
    • Li, W.W.1    Dammerman, M.M.2    Smith, J.D.3    Metzger, S.4    Breslow, J.L.5    Leff, T.6
  • 24
    • 79251523832 scopus 로고    scopus 로고
    • Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance
    • Kozlitina J, Boerwinkle E, Cohen JC, Hobbs HH. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology. 2011;53(2):467-74.
    • (2011) Hepatology. , vol.53 , Issue.2 , pp. 467-474
    • Kozlitina, J.1    Boerwinkle, E.2    Cohen, J.C.3    Hobbs, H.H.4
  • 25
    • 77950271973 scopus 로고    scopus 로고
    • Genetic susceptibility to hepatic steatosis
    • Diehl AM. Genetic susceptibility to hepatic steatosis. N Engl J Med. 2010;362(12):1142-3.
    • (2010) N Engl J Med. , vol.362 , Issue.12 , pp. 1142-1143
    • Diehl, A.M.1
  • 26
    • 0037098203 scopus 로고    scopus 로고
    • Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research
    • Sterne JA, Juni P, Schulz KF, Altman DG, Bartlett C, Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med. 2002;21(11):1513-24.
    • (2002) Stat Med. , vol.21 , Issue.11 , pp. 1513-1524
    • Sterne, J.A.1    Juni, P.2    Schulz, K.F.3    Altman, D.G.4    Bartlett, C.5    Egger, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.